Browse All
Displaying 1 - 2 of 2
Author:Logroscino, Giancarlo Piccininni, Marco Graff, Caroline Hardiman, Orla Ludolph, Albert Moreno, Fermin Otto, Markus Remes, Anne Rowe, James Seelaar, Harro Solje, Eino Stefanova, Elka Traykov, Latchezar Jelic, Vesna Rydell, Melissa Thaeri Pender, Niall Anderl-Straub, Sarah Barandiaran, Myriam Gabilondo, Alazne Kruger, Johanna Murley, Alexander Rittman, Timothy van der Ende, Emma L Van Swieten, John Hartikainen, Paivi Mandic Stojmenovic, Gorana Meherabian, Shima Benussi, Luisa Alberici, Antonella Dell'Abate, Maria Teresa Zecca, Chiara Borroni, Barbara
Session Name:S19: Neuroepidemiology
Topic:Neuroepidemiology
Program Number:S19.004
Author Institution:Center for Neurodegenerative Diseases and the Aging Brain, Pia Fondazione Cardinale Giovanni Panico, University of Bari-Aldo Moro, Bari, Italy, Tricase, Italy Institute of Public Health, Charité – Universitätsmedizin Berlin, Berlin, Germany, Berlin, Germany Department NVS, Division of Neurogeriatrics, Karolinska Institutet, Solna, Sweden, Solna, Sweden Trinity Biomedical Sciences Institute, Trinity College Dublin, Ireland Department of Neurology, University Hospital Ulm, Ulm, Germany, Ulm, Germany Cognitive Disorders Unit, Department of Neurology, Hospital Universitario Donostia, San Sebastian, Spain, San Sebastian, Spain Unit of Clinical Neuroscience, Neurology, University of Oulu, Oulu, Finland, Vantaa, Finland Department of Clinical Neurosciences, MRC Cognition and Brain Sciences Unit, and Cambridge University Hospitals NHS Cambridge, United Kingdom, Cambridge, United Kingdom Erasmus University Medical Center, Rotterdam, Netherlands Department of Neurology and Alzheimer Center Erasmus MC, Erasmus MC University Medical Center, Rotterdam, the Netherlands, Kuopio, Finland 19. Faculty of Medicine, Neurology Clinic, University Clinical Center, University of Belgrade, Serbia, Belgrade, Serbia UH Alexandrovska, Department of Neurology, Medical University Sofia, Sofia, Bulgaria, Sofia, Bulgaria Theme Inflammation and Aging, Medical Unit Aging Brain, Karolinska Universtity Hospital Huddinge, Solna, Sweden, Solna, Sweden Department of Neurology, Beaumont Hospital, Dublin, Ireland, Dublin, Ireland Unit of Clinical Neuroscience, Neurology, University of Oulu, Oulu, Finland, Oulu, Finland Department of Clinical Neurosciences, Cambridge, United Kingdom Department of Neurology and Alzheimer Center Erasmus MC, Erasmus MC University Medical Center, Rotterdam, the Netherlands, Rotterdam, Netherlands Kuopio University Hospital, Kuopio, Finland Faculty of Medicine, Neurology Clinic, University Clinical Center, University of Belgrade, Serbia, Belgrade, Serbia Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy, Brescia, Italy Centre for Neurodegenerative Disorders, Neurology Unit, ASST Spedali Civili Brescia and University of Brescia, Italy, Brescia, Italy
Author:Meier, Stephanie Benkert, Pascal Maleska Maceski, Aleksandra Schaedelin, Sabine Oechtering, Johanna Melie-Garcia, Lester Cagol, Alessandro Barakovic, Muhamed Galbusera, Riccardo Achtnichts, Lutz Lalive, Patrice H. Bridel, Claire Müller, Stefanie Pot, Caroline Salmen, Anke Disanto, Giulio Zecca, Chiara Abdelhak, Ahmed Barro, Christian Thebault, Simon D’Souza, Marcus Derfuss, Tobias Orleth, Annette Khalil, Michael Yaldizli, Özguer Hermesdorf, Marco Wiendl, Heinz Piehl, Fredrik Fischer, Urs Kappos, Ludwig Gobbi, Claudio Granziera, Cristina Leppert, David Willemse, Eline A.J. Kuhle, Jens
Session Name:P5: MS Prognosis/Epidemiology
Topic:MS and Inflammatory Disease
Program Number:P5.016
Author Institution:Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland, Basel, Switzerland Translational Imaging in Neurology (ThINK) Basel, Department of Biomedical Engineering Multiple Sclerosis Centre and Research Center for Clinical Neuroimmunology and Neuroscience (RC2NB), Departments of Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland, Allschwill, Basel, Switzerland Department of Neurology, Cantonal Hospital Aarau, Aarau, Switzerland, Aarau, Switzerland Department of Clinical Neurosciences, Division of Neurology, Unit of Neuroimmunology, University Hospital of Geneva and Faculty of Medicine, Geneva, Switzerland, Geneva, Switzerland Department of Neurology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland, St. Gallen, Switzerland Service of Neurology, Department of Clinical Neurosciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland, Lausanne, Switzerland Department of Neurology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland, Bern, Switzerland Multiple Sclerosis Center (MSC), Department of Neurology, Neurocenter of Southern Switzerland Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), Lugano, Switzerland, Lugano, Switzerland Weill Institute for Neurosciences, Department of Neurology, University of California at San Francisco (UCSF), San Francisco, California, USA, San Francisco, CA Department of Neurology, Harvard Medical School, Boston, MA, USA, Boston, MA Department of Medicine and the Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Canada, Ottowa, ON, Canada Department of Neurology, Medical University of Graz, Graz, Austria, Graz, Austria Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany, Münster, Germany Department of Neurology with Institute of Translational Neurology, University Hospital Münster, Münster, Germany, Muenster, Germany Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden Center for Neurology, Academic Specialist Center, Stockholm Health Services, Stockholm, Sweden, Stockholm, Sweden
